Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 4, Avril 2013
Page(s) 383 - 388
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2013294011
Publié en ligne 26 avril 2013
  1. Lallemant M, Jourdain G, Le Cœur S, et al. Prévention de la transmission mère-enfant du VIH : un protocole simple, d’une efficacité remarquable. Med Sci (Paris) 2005 ; 21 : 28–9. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Heidari S, Mofenson L, Cotton MF, et al. Antiretroviral drugs for preventing mother-to-child transmission of HIV: A review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr 2011 ; 57 : 290–6. [CrossRef] [PubMed] [Google Scholar]
  3. Mahy M, Stover J, Kiragu K, et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect 2010 ; 86 Suppl 2 : ii48–55. [CrossRef] [PubMed] [Google Scholar]
  4. Antiretroviral drugs for treating women and preventing HIV infection in infants. WHO guidelines. http://www.who.int/hiv; accessed 20 April 2012. [Google Scholar]
  5. Watts DH, Williams PL, Kacanek D, et al. Pediatric HIV/AIDS Cohort Study. Combination antiretroviral use and preterm birth. J Infect Dis 2013 ; 207 : 612–21. [CrossRef] [PubMed] [Google Scholar]
  6. Sibiude J, Warszawski J, Tubiana R, et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost ? Clin Infect Dis 2012 ; 54 : 1348–60. [CrossRef] [PubMed] [Google Scholar]
  7. Warszawski J, Le Chenadec J, Mandelbrot L, et al. and the French Perinatal Cohort** (ANRS CO1/CO11). Infant mortality among HIV-uninfected children during the HAART Era in France – The ANRS French perinatal cohort. Poster n° 1032 presented at the 19th CROI, Seattle 2012. [Google Scholar]
  8. Chou R, Cantor A, Bougatsos C, Zakher B. Screening for HIV in pregnant women: systematic review to update the U.S. preventive services task force recommendation. 2012. Rockville (MD) : Agency for healthcare research and quality (US), Available from http://www.ncbi.nlm.nih.gov/books/NBK114880. [Google Scholar]
  9. http://whqlibdoc.who.int/publications/2012/9789241503792_eng.pdf. [Google Scholar]
  10. Ford N, Calmy A, Mofenson L.. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS 2011 ; 25 : 2301–4. [CrossRef] [PubMed] [Google Scholar]
  11. Knapp KM, Brogly SB, Muenz DG, et al. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J 2012 ; 31 : 164–70. [CrossRef] [PubMed] [Google Scholar]
  12. Sibiude J, Mandelbrot L, Blanche S, et al. Birth defects and antiretroviral therapy: Zidovudine in the first trimester is associated to congenital heart defects in the EPF French perinatal xohort. JAMA 2013 (sous presse). [Google Scholar]
  13. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS clinical trials group protocol 076 study group. N Engl J Med 1994 ; 331 : 1173–80. [CrossRef] [PubMed] [Google Scholar]
  14. Crain MJ, Williams PL, Griner R, et al. Pediatric HIVAIDS Cohort Study. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications. Pediatr Infect Dis J 2011 ; 30 : 1069–74. [CrossRef] [PubMed] [Google Scholar]
  15. Blanche S.. Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. AIDS 2006 ; 20 : 1685–90. [CrossRef] [PubMed] [Google Scholar]
  16. Divi RL, Leonard SL, Kuo MM, et al. Cardiac mitochondrial compromise in one year old Erythrocebus patas monkeys exposed in utero to nucleoside reverse transcriptase inhibitors. Cardiovasc Toxicol 2005 ; 5 : 333–46. [CrossRef] [PubMed] [Google Scholar]
  17. Dauby N, Goetghebuer T, Kollmann TR, et al. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis 2012 ; 12 : 330–40. [CrossRef] [PubMed] [Google Scholar]
  18. Ross AC, Leong T, Avery A, et al. Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress. HIV Med 2012 ; 13 : 98–106. [CrossRef] [PubMed] [Google Scholar]
  19. Simon A, Warszawski J, Kariyawasam D, et al. Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers. JAMA 2011 ; 306 : 70–8. [CrossRef] [PubMed] [Google Scholar]
  20. http://www.fda;gov/Safety/Med Watch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm246167.htm. [Google Scholar]
  21. Olivero OA, Shearer GM, Chougnet CA, et al. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS 1999 ; 13 : 919–25. [CrossRef] [PubMed] [Google Scholar]
  22. Escobar PA, Olivero OA, Wade NA, et al. Genotoxicity assessed by the comet and GPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother-child pairs to AZT or AZT-3TC. Environ Mol Mutagen 2007 ; 48 : 330–43. [CrossRef] [PubMed] [Google Scholar]
  23. Witt KL, Cunningham CK, Patterson KB, et al. Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV. Environ Mol Mutagen 2007 ; 48 : 322–9. [CrossRef] [PubMed] [Google Scholar]
  24. Senda S, Blanche S, Costagliola D, et al. Altered heterochromatin organization after perinatal exposure to zidovudine. Antivir Ther 2007 ; 12 : 179–87. [PubMed] [Google Scholar]
  25. Olivero OA. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen 2007 ; 48 : 215–23. [CrossRef] [PubMed] [Google Scholar]
  26. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999 ; 354 : 1084–9. [CrossRef] [PubMed] [Google Scholar]
  27. Brogly SB, DiMauro S, Van Dyke RB, et al. Transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children. AIDS Res Hum Retroviruses 2011 ; 27 : 777–83. [CrossRef] [PubMed] [Google Scholar]
  28. Lipshultz SE, Shearer WT, Thompson B, et al. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: The NHLBI CHAART-1 cohort study. J Am Coll Cardiol 2011 ; 57 : 76–85. [CrossRef] [PubMed] [Google Scholar]
  29. Cade WT, Waggoner AD, Hubert S, et al. Reduced diastolic function and left ventricular mass in HIV-negative pre-adolescent children exposed to antiretroviral therapy in utero. AIDS 2012 ; 26 : 2053–8. [CrossRef] [PubMed] [Google Scholar]
  30. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S.. Enquête périnatale française study group. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 2003 ; 17 : 2053–61. [CrossRef] [PubMed] [Google Scholar]
  31. Pacheco SE, McIntosh K, Lu M, et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: an analysis of the women and infants transmission study. J Infec Dis 2006 ; 194 : 1089–97. [CrossRef] [Google Scholar]
  32. Bunders MJ, Bekker V, Scherpbier HJ, et al. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr 2005 ; 94 : 1571–7. [CrossRef] [PubMed] [Google Scholar]
  33. Andre-Schmutz I, Dal-Cortivo L, Six E, et al. Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination. J Inf Dis 2013 ; sous presse. [Google Scholar]
  34. Olivero O, Torres LR, Gorjifard S, et al. Perinatal exposure of patas monkeys to antiretroviral nucleoside reverse transcriptase inhibitors induces genotoxicity persistent for up to 3 years of age. J Infect Dis 2013 ; sous presse. [Google Scholar]
  35. Benhammou V, Warszawski J, Bellec S, et al. Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors. AIDS 2008 ; 22 : 2165–77. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.